Literature DB >> 14736016

Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy.

Kai Ming Chow1, Cheuk Chun Szeto, Leo Chi-Chiu Kum, Bonnie Ching Ha Kwan, Terence Ming-Kit Fung, Teresa Yuk-Hwa Wong, Chi Bon Leung, Philip Kam-Tao Li.   

Abstract

BACKGROUND: We prospectively studied changes in the perception of health-related quality of life, pruritus, and degree of left ventricular hypertrophy in end-stage renal disease patients with tertiary hyperparathyroid disorder, before and 6 months after total parathyroidectomy treatment.
METHODS: A series of 12 consecutive patients were enrolled. Throughout the follow-up period, all subjects completed the Kidney Disease Quality of Life Short Form-36 (KDQOL SF-36) questionnaire at inclusion and after 6 months. Serial clinical and physiological parameters including uremic pruritus, blood pressure control and left ventricular hypertrophy measured by echocardiography were recorded.
RESULTS: Mean scores of the KDQOL SF-36 questionnaires were substantially higher 6 months after parathyroidectomy, with reference to physical functioning, bodily pain, role-physical, role-emotional, symptom list and burden of kidney disease. Parathyroidectomy resulted in a 22% reduction in left ventricular mass index, with significant improvement from the baseline value of 246 +/- 131 to 192 +/- 131 g/m2 (p = 0.03).
CONCLUSION: Our findings highlight the potential importance of parathyroidectomy in improving health-related quality of life and left ventricular hypertrophy among dialysis patients with tertiary hyperparathyroidism.

Entities:  

Mesh:

Year:  2003        PMID: 14736016

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  10 in total

1.  Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.

Authors:  Noriyuki Iwamoto; Nodoka Sato; Masaya Nishida; Tetsuya Hashimoto; Hiroyuki Kobayashi; Satoru Yamazaki; Koji Okino; Masato Nishimura; Toru Takatani; Yu Okamoto; Tsuneyuki Nakanouchi; Masaki Koyama; Naoto Adachi; Kanji Ninomiya; Hisao Mabuchi; Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2015-12-17       Impact factor: 2.801

2.  The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Authors:  T I Chang; S Abdalla; G M London; G A Block; R Correa-Rotter; T B Drüeke; J Floege; C A Herzog; K W Mahaffey; S M Moe; P S Parfrey; D C Wheeler; B Dehmel; W G Goodman; G M Chertow
Journal:  J Hum Hypertens       Date:  2015-06-04       Impact factor: 3.012

3.  Increasing Age Hinders the Decline in B-Type Natriuretic Peptide Following Parathyroidectomy in Dialysis Patients.

Authors:  Tun-Pang Chu; Po-Sheng Yang; Jie-Jen Lee; Chih-Jen Wu; Shih-Ping Cheng
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

4.  Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism.

Authors:  Theresia Weber; Martin Zeier; Ulf Hinz; Tobias Schilling; Markus W Büchler
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

5.  Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.

Authors:  Rajan K Patel; Scott Oliver; Patrick B Mark; Joanna R Powell; Emily P McQuarrie; James P Traynor; Henry J Dargie; Alan G Jardine
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

6.  Parathyroidectomy and heart rate variability in patients with stage 5 CKD.

Authors:  Jing Zhang; Xiangbao Yu; Bin Sun; Jianling Bai; Yongyue Wei; Xiaoming Zha; Yiyao Cui; Ming Zeng; Jingjing Zhang; Jia Liu; Huijuan Mao; Bo Zhang; Haibin Ren; Yifei Ge; Xueqiang Xu; Zhixiang Shen; Changying Xing; Kejiang Cao; Ningning Wang
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

7.  Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.

Authors:  L-N Zhang; G Yang; C Cheng; C Shen; Y-Y Cui; J Zhang; J-J Zhang; Z-X Shen; M Zeng; Y-F Ge; B Sun; X-B Yu; C Ouyang; B Zhang; H-J Mao; J Liu; C-Y Xing; X-M Zha; N-N Wang
Journal:  Osteoporos Int       Date:  2014-09-16       Impact factor: 4.507

8.  SURGERY OUTCOMES IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM AND IMPACT OF INTRA-OPERATIVE PTH MEASUREMENT.

Authors:  A B Amza; V Muntean; G Dindelegan; C Ciuce; C E Georgescu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

9.  Effect of Parathyroidectomy on Quality of Life Among Patients Undergoing Dialysis.

Authors:  Lin Wang; Ming-Hui Xin; Yan Ma; Yu Wang; Meng-Yuan Hu; Qiang-Qiang Liu; Jin-Bor Chen
Journal:  Int J Gen Med       Date:  2022-02-05

10.  Full normalization of severe hypertension after parathryoidectomy - a case report and systematic review.

Authors:  Andreea Corina Sofronie; Isabelle Kooij; Claude Bursot; Giulia Santagati; Jean-Philippe Coindre; Giorgina Barbara Piccoli
Journal:  BMC Nephrol       Date:  2018-05-11       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.